A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation

R. A. Clift, J. A. Bianco, F. R. Appelbaum, C. D. Buckner, J. W. Singer, L. Bakke, W. I. Bensinger, R. A. Bowden, G. B. McDonald, M. Schubert, A. F. Shields, J. T. Slattery, R. Storb, L. D. Fisher, M. Mori, E. D. Thomas, J. A. Hansen

    Research output: Contribution to journalArticlepeer-review

    89 Scopus citations

    Abstract

    This study evaluated the effect of pentoxifylline (PTX) on the incidence of regimen-related toxicity in patients receiving allogeneic marrow transplants from related donors. All patients received a regimen of methotrexate and cyclosporine as prophylaxis against acute graft-versus-host disease (GVHD). Patients were randomized to receive PTX or a placebo for 70 days and the outcome was examined in a blinded fashion. Forty-four patients were evaluable in each study arm. PTX had no significant effect on engraftment, the incidence of GVHD, venocclusive disease of the liver, infection, the need for oxygen, posttransplant survival, or the duration of hospitalization. Patients receiving PTX were significantly more likely to develop major elevations of serum creatinine levels. PTX was poorly tolerated and induced significantly more vomiting than the placebo. PTX as administered in this randomized study was associated with significant toxicity and offered no benefit in reducing transplant-related morbidity or mortality.

    Original languageEnglish (US)
    Pages (from-to)2025-2030
    Number of pages6
    JournalBlood
    Volume82
    Issue number7
    DOIs
    StatePublished - 1993

    ASJC Scopus subject areas

    • Biochemistry
    • Immunology
    • Hematology
    • Cell Biology

    Fingerprint Dive into the research topics of 'A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation'. Together they form a unique fingerprint.

    Cite this